AIVF vs CytoReason
AIVF vs CytoReason, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: AIVF is on 63/100 and CytoReason on 68/100.
Where each one leads
AIVF
- agent readiness: 50/100 against 21/100
- headcount growth: +65.5% against +13.7%
CytoReason
- our overall score: 68/100 against 63/100
- headcount: 116 against 53
- funding raised: $128M against $25.0M
- LinkedIn following: 12,830 against 5,710
At a glance
| Measure | AIVF | CytoReason |
|---|---|---|
| What it is | AI-powered IVF clinic solutions for digitization and automation. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, InVitro Fertilization (IVF), Fertility, HealthTech | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | AIVF | CytoReason |
|---|---|---|
| Employees | 53 | 116 |
| Headcount growthLast 12 months | +65.5% | +13.7% |
| Total funding | $25.0M | $128M |
| Latest round | Series A | Series B |
| LinkedIn followers | 5,710 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | AIVF | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 68/100 |
| Traction | 54/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 38/100 | 30/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 37/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | AIVF | CytoReason |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| Analytics | Not detected | Segment |
AIVF vs CytoReason: common questions
Which is better, AIVF or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 63/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do AIVF and CytoReason compare on the numbers?
AIVF leads on agent readiness (50/100 against 21/100), headcount growth (+65.5% against +13.7%). CytoReason leads on our overall score (68/100 against 63/100), headcount (116 against 53), funding raised ($128M against $25.0M), LinkedIn following (12,830 against 5,710).
Read the full AIVF review and pricing or the CytoReason review and pricing. You can also browse other AIVF alternatives we track.